ctrl K

Price Alert

Marrone Bio Innovations I... (MBII)

NASDAQ: MBII · Real-Time Price · USD

0.80

-0.20 (-20.00%)

At close: Apr 24, 2025, 3:47 PM

Marrone Bio Innovations Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	44.37M	44.31M	33.59M	32.56M	32.14M
Cost of Revenue	17.89M	17.06M	12.75M	12.77M	12.73M
Gross Profit	26.48M	27.25M	20.85M	19.8M	19.41M
Operating Income	-18.68M	-14.65M	-13.88M	-14.91M	-14.56M
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-20.9M	-16.51M	-11.2M	-12.28M	-12.07M
Net Income	-20.89M	-16.55M	-11.24M	-12.36M	-12.19M
Selling & General & Admin	33.16M	30.57M	22.11M	22.18M	21.97M
Research & Development	12.72M	12.08M	8.57M	8.49M	7.97M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	45.88M	42.65M	30.68M	30.67M	29.94M
Interest Expense	1.73M	1.57M	1.12M	1.16M	1.13M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	63.77M	59.71M	43.43M	43.44M	42.67M
Income Tax Expense	-7K	45K	41K	81K	124K
Shares Outstanding (Basic)	182.26M	175.57M	176.55M	175.57M	168.94M
Shares Outstanding (Diluted)	182.26M	175.57M	176.55M	175.57M	168.94M
EPS (Basic)	-0.12	-0.09	-0.09	-0.11	-0.11
EPS (Diluted)	-0.12	-0.09	-0.06	-0.08	-0.08
EBITDA	-14.5M	-10.37M	-6.39M	-7.5M	-7.39M
EBIT	-19.17M	-14.94M	-10.08M	-11.12M	-10.94M
Depreciation & Amortization	4.67M	4.57M	3.69M	3.62M	3.55M